Download PDF
Thromb Haemost 1993; 69(01): 092-093
DOI: 10.1055/s-0038-1651560
Letter to the Editor
Schattauer GmbH Stuttgart

Contact Activation, Heparins and Cardiopulmonary Bypass

M J Gallimore
Abt. für Herz-, Thorax- und Gefäßchirurgie, Universität Tübingen, Tübingen, Germany
,
W Heller
Abt. für Herz-, Thorax- und Gefäßchirurgie, Universität Tübingen, Tübingen, Germany
,
G Fuhrer
Abt. für Herz-, Thorax- und Gefäßchirurgie, Universität Tübingen, Tübingen, Germany
,
H Wendel
Abt. für Herz-, Thorax- und Gefäßchirurgie, Universität Tübingen, Tübingen, Germany
,
R Klaffschenkel
Abt. für Herz-, Thorax- und Gefäßchirurgie, Universität Tübingen, Tübingen, Germany
,
H-E Hoffmeister
Abt. für Herz-, Thorax- und Gefäßchirurgie, Universität Tübingen, Tübingen, Germany
› Author Affiliations
Further Information

Publication History

Received 24 August 1992

Accepted after revision 01 September 1992

Publication Date:
04 July 2018 (online)

Also available at
  PDF Download  Permissions and Reprints
 

  • References

  • 1 Pixley RA, Colman RW. Response to the Letter to the Editor by M.J. Gallimore et al. Thromb Haemostas 1992; 68: 93-94
    PubMedSearch in Google Scholar
  • 2 Gallimore MJ, Heller W, Fuhrer G, Wendel H, Klaffschenkel R, Hoffmeister H-E. Contact activation, heparins and cardiopulmonary bypass. Thromb Haemostas 1992; 68: 91-92
    PubMedSearch in Google Scholar
  • 3 Gallimore MJ, Friberger P. Simple chromogenic peptide substrate assays for determining prekallikrein, kallikrein inhibition and kallikrein “like” activity in human plasma. Thromb Res 1982; 25: 293-298
    CrossrefPubMedSearch in Google Scholar
  • 4 Friberger P, Aurell L, Rees W, Gallimore MJ. Studies on synthetic peptide substrates for FXII enzymes. In: KININS IV. Advances in Experimental Medicine and Biology. Vol 198 B Greenbaum LW, Margolis H. (eds). Plenum Press; New York: 1986: 53-61
    Search in Google Scholar
  • 5 Kierulf P, Aasen AO, Aune S, Godal HC, Rund TE, Vaage J. Chromogenic peptide substrate assays in patients with multiple trauma. In: Significance of Chromogenic Peptide Substrate Assays in Critical Care Medicine. Acta Chir Scand Suppl 509 Aasen AO, Amundsen E, Kierulf P. (eds). Albedon/Klop bv; Katwijk, The Netherlands: 1982: 69-72
    Search in Google Scholar
  • 6 Harpel PC. Plasmin inhibitor interactions. The effectiveness of α2-plasmin inhibitor in the presence of α2-macroglobulin. J Exp Med 1977; 146: 1033-1040
    CrossrefPubMedSearch in Google Scholar
  • 7 Gallimore MJ. Chromogenic peptide substrate assays for determining components of the plasma kallikrein system. Scand J Clin Lab Invest 1985; 45 (Suppl. 178) 127-132
    PubMedSearch in Google Scholar
  • 8 Harpel PC, Lewin MF, Kaplan AP. Distribution of plasma kallikrein between C1-inactivator and α2-macroglobulin in plasma utilising a new assay for α2-macroglobulin-kallikrein complexes. J Biol Chem 1985; 260: 4257-4263
    PubMedSearch in Google Scholar
  • 9 Pixley RA, Cassello A, De La Cadena RA, Kaufman N, Colman RW. Effect of heparin on the activation of Factor XII and the contact system in plasma. Thromb Haemostas 1991; 66: 540-547
    PubMedSearch in Google Scholar
  • 10 Kaufman N, Page JD, Pixley RA, Schein R, Schmaier AH, Colman RW. α2-Macroglobulin-kallikrein complexes detect contact system activation in hereditary angioedema and human sepsis. Blood 1991; 77: 2660-2667
    PubMedSearch in Google Scholar